Skip navigation

Chemical 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid

Name 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid
Equivalent Term 2,5-DCDOPA
CAS Registry Number 92773-66-5
Structure 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid
Curation Status No associations have been curated for this chemical yet.
MeSH® ID C052007
External Links

Top ↑ Ancestors

1. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Amides Has associated genes Has associated diseases Has associated exposure references Lactams Has associated genes Has associated diseases beta-Lactams Has associated genes Has associated diseases Penicillins Has associated genes Has associated diseases 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid
2. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Sulfur Compounds Has associated genes Has associated diseases Has associated exposure references beta-Lactams Has associated genes Has associated diseases Penicillins Has associated genes Has associated diseases 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid
3. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 2-Ring Has associated genes Has associated diseases Has associated exposure references beta-Lactams Has associated genes Has associated diseases Penicillins Has associated genes Has associated diseases 6-(2-(3-(2,5-dichloro-3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido)-2-phenylacetamido)penicillanic acid

Top ↑ Descendants

None.